Saturday morning Q & A (2017 Conference) (LDN, low dose naltrexone)

Saturday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Dr Armin Schwarzbach - Lyme Disease (2014 Conference) (LDN, low dose naltrexone)

Stephen Dickson - The pharmacology of LDN (2014 Conference) (LDN, low dose naltrexone)

Pharmacist-Prescriber Michael McCaughley - LDN Specialist (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

The LDN Research Trust's 8th LDN Specialist

Pharmacist Masoud Rashidi, PharmD - LDN Specialist (LDN, low-dose Naltrexone) from LDN Research Trust on Vimeo.

Use of LDN for Chronic Pain - Sahar Swidan, PHARM.D., ABAAHP, FAARFM, FACA (2021 Conference) (LDN, low dose naltrexone)

This talk is on the use of LDN for chronic pain. She reviews LDN’s actions in the CNS and the PNS, the immunomodulating effect of LDN, and some clinical trials on the use of LDN.

The Use of LDN for Ophthalmic Conditions - Sebastian Denison, Pharm (2021 Conference) (LDN, low dose naltrexone)

This talk is about how they utilize LDN, their LDN protocol, and their outcomes and expectations. The information presented about humans can apply to animals as well.

Hypothyroidism - Dawn Ipsen, PharmD (2021 Conference) (LDN, low dose naltrexone)

Dr. Dawn Ipsen is a compounding pharmacist who presents on some roles low dose naltrexone (LDN) may have in helping patients with hypothyroidism. She discusses hypothyroidism, its prevalence, and treatment goals. 

Developing outcome centric, territory-specific access protocols for the provision of niche product - John Bardsley (2021 Conference) (LDN, low dose naltrexone)

John Bardsley is managing director of Thistle Pharma Ltd. LDN is an unlicensed medicine. Much of what he is talking about pertains specifically to the UK sector, and may apply to your own territories as well.